Pay in 4 interest-free payments of $7.37 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Retatrutide is an investigational triple-hormone receptor agonist developed by Eli Lilly that targets three receptors: GIP (glucose-dependent insulinotropic polypeptide), GLP-1 (glucagon-like peptide-1), and glucagon
Compounded drugs are not FDA-approved
Typical research-related considerations include: Vehicle and Diluent Use Researchers often use bacteriostatic water as a vehicle in: Reconstituting powdered or lyophilized research materials Preparing working solutions from concentrated stock materials Supporting solubility or dispersion of compatible compounds in aqueous systems The benzyl alcohol content helps limit microbial growth in the container between uses, which can be beneficial when small aliquots are drawn repeatedly under sterile conditions
Important Notice: This product is not intended for human consumption, medical use, or therapeutic applications
While theres a substantial body of animal research supporting its regenerative effects, we do not yet have conclusive clinical evidence to guarantee long-term safety or efficacy in humans
The frequency of your B12 injection schedule will depend on your individual situation and the size of the dose
US$ 28.29
US$ 28.84
US$ 28.77
US$ 26.83
US$ 29.76
US$ 24.40
US$ 24.16
US$ 25.90
